Immunophotonics receives green light from FDA to open IND study
May 16, 2023 | Company
Immunophotonics has announced the U.S. Food and Drug Administration (FDA) completed its safety review of the com...
Read more >
Climeworks confirms expansion to U.S.
April 19, 2023 | Company
To accelerate deployment in the U.S., Climeworks has applied to participate in three hubs as part of the U.S. De...
Read more >
SkyCell welcomes Lazard Asset Management as a shareholder
April 18, 2023 | Company
SkyCell is pleased to welcome Lazard Asset Management as a new shareholder, following their recent acquisition o...
Read more >
CUTISS announces positive Phase 2 clinical trial results for denovoSkin™
April 3, 2023 | Company
CUTISS AG has announced positive results from the Phase 2 clinical trial of its lead product denovoSkin™, in a...
Read more >
Youngest patient ever treated with denovoSkin – a neonatal case
March 28, 2023 | Company
The paper published in Burns Open has presented the case of a four day-old neonate suffering from life threateni...
Read more >
Advanced testing of human skin cells on the International Space Station
March 15, 2023 | Company
CUTISS AG has announced the start of an advanced research and development mission on board the International Spa...
Read more >